Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 179.67M P/E - EPS this Y 36.50% Ern Qtrly Grth -
Income -102.04M Forward P/E -2.49 EPS next Y 12.30% 50D Avg Chg 18.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg 39.00%
Dividend N/A Price/Book 1.35 EPS next 5Y - 52W High Chg -77.00%
Recommedations 1.70 Quick Ratio 5.81 Shares Outstanding 81.43M 52W Low Chg 117.00%
Insider Own 1.04% ROA -27.57% Shares Float 59.75M Beta 2.36
Inst Own 52.18% ROE -66.26% Shares Shorted/Prior 9.45M/9.78M Price 4.59
Gross Margin - Profit Margin - Avg. Volume 548,930 Target Price 26.25
Oper. Margin - Earnings Date Oct 31 Volume 680,226 Change -6.13%
About Mind Medicine (MindMed) Inc.

Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.

Mind Medicine (MindMed) Inc. News
12/19/24 MindMed to Be Added to the Nasdaq Biotechnology Index
12/16/24 MindMed Announces First Patient Dosed in Phase 3 Voyage Study of MM120 in Generalized Anxiety Disorder (GAD)
12/11/24 MindMed Scientific Presentations at American College of Neuropsychopharmacology (ACNP) 2024 Congress
12/05/24 MindMed Awarded Innovation Passport Designation by the United Kingdom (UK) Innovative Licensing and Access Pathway (ILAP) Steering Group for MM120 Orally Disintegrating Tablet (ODT) for Generalized Anxiety Disorder (GAD)
12/03/24 MindMed Appoints Javier Muniz, M.D., as Vice President of Research and Development Strategy
12/02/24 MindMed Announces New Employee Inducement Grants
11/18/24 MindMed Appoints Gregg Pratt, Ph.D. as Chief Regulatory and Quality Assurance Officer
11/14/24 Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) market cap touched US$601m last week, benefiting both retail investors who own 41% as well as institutions
11/13/24 MindMed to Participate in Upcoming Investor Conferences
11/07/24 MindMed Reports Third Quarter 2024 Financial Results and Business Updates
10/24/24 MindMed to Host Conference Call and Webcast to Discuss Third Quarter 2024 Financial Results and Provide Business Update
10/12/24 Mind Medicine assumed with an Outperform at Leerink
09/04/24 MindMed to Participate in September Investor Conferences
08/13/24 MindMed Reports Second Quarter 2024 Financial Results and Business Updates
08/12/24 Weekly Roundup on the Cannabis Sector & Psychedelic Sector
08/09/24 Mind Medicine (MindMed) Inc. Announces Pricing of Public Offering
08/09/24 Mind Medicine (MindMed) Inc. Announces Proposed Public Offering
08/06/24 MindMed to Present at Canaccord Genuity’s 44th Annual Growth Conference
08/06/24 MindMed to Host Conference Call and Webcast to Discuss Second Quarter 2024 Financial Results and Provide Business Update
07/29/24 MindMed Appoints Stephanie Fagan as Chief Corporate Affairs Officer
MNMD Chatroom

User Image ItsCarRamRod Posted - 24 minutes from now

$MNMD just an average day down for mnmd

User Image BobbyCucumber1 Posted - 23 minutes from now

$MNMD Adding, been waiting for this, have faith!

User Image Cashtonll2 Posted - 16 minutes from now

$MNMD 6.70 breaks I’m out

User Image Need4Speed123 Posted - 7 minutes from now

$MNMD bought more here…no brainer!

User Image Cashtonll2 Posted - 2 minutes from now

Back in $6.91 give me one more bounce before year end please $MNMD

User Image goral17 Posted - 1 hour ago

$MNMD some puts are up 800+% Remember, the options market leads the stock market

User Image EMT6 Posted - 19 hours ago

$MNMD starting , 50% today almost . That’s already a dub

User Image zcurrency Posted - 19 hours ago

$MNMD

User Image BullsVSBearsVSYoMomma Posted - 19 hours ago

$MNMD

User Image NVDAMillionaire Posted - 19 hours ago

$MNMD Mind Medicine (NASDAQ: MNMD): Charting a Path in Psychedelics Therapeutics https://beyondspx.com/article/mind-medicine-nasdaq-mnmd-charting-a-path-in-psychedelics-therapeutics

User Image BobbyCucumber1 Posted - 1 day ago

$MNMD Good consolidation, chart, trials, uplisting, sentiment, support holding, just a matter of time before this one pops!!! $20 in a year, hopefully sooner...

User Image MichaelNaussCMT Posted - 1 day ago

$CYBN $MNMD

User Image mcgr Posted - 2 days ago

$MNMD Hard to see MNMD as anything but the leader now, high cash reserves, phase 3 inbound, and burn rate is understandable. $CYBN seems like a close second, but the burn rate is unsustainable, so we’re going to have to see dilution of some kind pre phase 3 read out. Regardless, one of these two will get across the finish line.

User Image mcgr Posted - 2 days ago

$MNMD $CYBN $ATAI $CMPS all nearing or at inflection points on their respective prices. Either we dip heavily below the former zones, or we rebound, but we may get a very good buying opportunity in the new year if some of these levels break. (CMPS $4, MNMD $7, ATAI $1, CYBN $9)

User Image OrganizedChaos Posted - 2 days ago

$MNMD Monthly Support @ 7.17, Res @ 8.63, next res @ 11.11

User Image stoxx0007 Posted - 2 days ago

$META $HOOD $CMPS $MNMD $CYBN

User Image EMT6 Posted - 3 days ago

$MNMD took some $7.5 calls 01/17 @ 0.45

User Image BobbyCucumber1 Posted - 3 days ago

$MNMD Once again, great cup and handle...

User Image twiggs462 Posted - 3 days ago

$MNMD https://www.youtube.com/watch?v=UdergwXRj9A

User Image stoxx0007 Posted - 4 days ago

$PSYCF = chart showing a double bottom is in and PSYCF is going UP from here! $ATAI $CYBN $MNMD $CMPS

User Image Beachlife22 Posted - 4 days ago

$MNMD

User Image twiggs462 Posted - 5 days ago

$MNMD Docket Number: FDA-2023-D-1987: Psychedelic Drugs: Considerations for Clinical Investigations; Draft Guidance for Industry; Availability https://downloads.regulations.gov/FDA-2023-D-1987-0197/attachment_1.pdf HOLD!!!!!!!!!!!!!!!!!!

User Image LinkupInvest Posted - 6 days ago

$MNMD

User Image GoldenBull13 Posted - 6 days ago

$MNMD Zooming out on the weekly log chart, we have a cup and handle formed along with an ascending channel. Breaking past $12 would be the breakout point of the cup and handle and would confirm the trend.

User Image trading_momentum Posted - 6 days ago

$MNMD yesterday news which dumped hard post FOMC. Will look to re-visit more MNMD long term again

User Image Stantarizen Posted - 6 days ago

$ATXS $MNMD 🔥 MYNZ 86% in 2 days move! FDA fast-track soon Petra’s Hint on X, 88% accuracy (unlike EXAS 42 % \ GH 20%), strong partners (DGX, TMO). $50-$100 target by Q2 2025. 🚀

User Image twiggs462 Posted - 6 days ago

$ATAI this one and $MNMD will be the leading two stocks in 2025.

User Image twiggs462 Posted - 6 days ago

$MNMD Updates for those that missed them: MindMed Announces First Patient Dosed in Phase 3 Voyage Study of MM120 in Generalized Anxiety Disorder (GAD) https://www.businesswire.com/news/home/20241216046321/en/ MindMed to Be Added to the Nasdaq Biotechnology Index https://www.businesswire.com/news/home/20241219955108/en/ Corporate Presentation December 2024 https://d1io3yog0oux5.cloudfront.net/_80b2b065dd756bcc65a56ab23eb57ef8/mindmed/db/2265/21500/pdf/MindMed+Investor+Presentation+December+2024+.pdf

User Image Dumb_money_big_gains Posted - 6 days ago

$MNMD I have a feeling psychedelic companies will have a crazy run in 2025. Euphoria interest has moved from AI -> space -> drones -> quantum -> ? There is always the next flavor of the month

User Image huskyd97 Posted - 6 days ago

$MNMD needs to break $10 for a meaningful fun! Maybe Monday another good pop?

Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Karlin Dan Chief Medical Office.. Chief Medical Officer Dec 26 Sell 3.63 6,774 24,590 365,030 12/26/23
Barrow Robert Chief Executive Offi.. Chief Executive Officer Dec 26 Sell 3.63 13,237 48,050 596,721 12/26/23
Greenway Schond L. Chief Financial Offi.. Chief Financial Officer Dec 26 Sell 3.63 5,652 20,517 216,617 12/26/23
Barrow Robert Chief Executive Offi.. Chief Executive Officer Sep 25 Sell 3.58 13,499 48,326 611,729 09/25/23
Karlin Dan Chief Medical Office.. Chief Medical Officer Sep 25 Sell 3.58 6,918 24,766 371,804 09/25/23
Greenway Schond L. Chief Financial Offi.. Chief Financial Officer Sep 25 Sell 3.58 5,762 20,628 222,269 09/25/23
Greenway Schond L. Chief Financial Offi.. Chief Financial Officer Aug 25 Sell 3.8 20,000 76,000 228,031 08/28/23
Barrow Robert Chief Executive Offi.. Chief Executive Officer Jun 27 Sell 3.2 15,502 49,606 623,457 06/27/23
Karlin Dan Chief Medical Office.. Chief Medical Officer Jun 27 Sell 3.2 6,783 21,706 378,722 06/27/23
Greenway Schond L. Chief Financial Offi.. Chief Financial Officer Jun 27 Sell 3.2 11,635 37,232 248,031 06/27/23
Karlin Dan Chief Medical Office.. Chief Medical Officer Mar 01 Sell 3.51 3,577 12,555 260,505 03/02/23
Barrow Robert Chief Executive Offi.. Chief Executive Officer Mar 01 Sell 3.51 8,273 29,038 238,959 03/02/23
Karlin Dan Chief Medical Office.. Chief Medical Officer Oct 25 Sell 2.91 1,185 3,448 265,293 10/27/22
Barrow Robert Chief Executive Offi.. Chief Executive Officer Oct 18 Sell 3.11 1,220 3,794 252,300 10/18/22
Karlin Dan Chief Medical Office.. Chief Medical Officer Sep 26 Sell 5.69 1,205 6,856 266,478 09/27/22
Karlin Dan Chief Medical Office.. Chief Medical Officer Aug 31 Sell 11.67 1,204 14,051 267,683 09/01/22
Barrow Robert Chief Executive Offi.. Chief Executive Officer Aug 31 Sell 11.67 1,228 14,331 256,134 09/01/22
Barrow Robert Chief Executive Offi.. Chief Executive Officer Aug 16 Sell 0.68 20,350 13,838 3,860,438 08/17/22
Karlin Dan Chief Medical Office.. Chief Medical Officer Jul 25 Sell 0.69 18,217 12,570 4,033,264 07/27/22
Barrow Robert Chief Executive Offi.. Chief Executive Officer Jul 25 Sell 0.69 18,681 12,890 3,880,788 07/26/22
Barrow Robert Chief Executive Offi.. Chief Executive Officer Jul 18 Sell 0.70 19,388 13,572 3,899,469 07/18/22
Barrow Robert Chief Executive Offi.. Chief Executive Officer Jun 27 Sell 0.70 36,762 25,733 3,918,857 06/28/22
Karlin Dan Chief Medical Office.. Chief Medical Officer Jun 27 Sell 0.70 26,238 18,367 4,051,481 06/28/22
Barrow Robert Chief Executive Offi.. Chief Executive Officer Jun 16 Sell 0.70 21,275 14,892 3,955,619 06/21/22
Karlin Dan Chief Medical Office.. Chief Medical Officer May 27 Sell 0.82 9,555 7,835 4,077,719 05/31/22
Barrow Robert Chief Executive Offi.. Chief Executive Officer May 25 Sell 0.77 18,415 14,180 3,976,894 05/26/22
Karlin Dan Chief Medical Office.. Chief Medical Officer May 25 Sell 0.77 8,242 6,346 4,087,274 05/26/22